UBE2I and central nervous system cancer: This study found that the expression of UBE2I was significantly increased in glioma cells, which promoted PUM2 SUMOylation, led to the degradation of PUM2 protein, and inhibited the role of PUM2 protein in the degradation of CEBPD mRNA.